Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine
(mIBG) scans in patients with relapsed neuroblastoma.
Torres, "Myocardial iodine-labeled metaiodobenzylguanidine
123 uptake relates to age," Journal of Nuclear Cardiology, vol.
Yamamoto et al., "Diagnostic accuracy of cardiac metaiodobenzylguanidine
scintigraphy in Parkinson disease," European Journal of Neurology, vol.
Myocardial iodine-123 metaiodobenzylguanidine
imaging and cardiac events in heart failure.
scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
and iii In octreotide uptake in benign and malignant pheochromocytomas.
Imaging the heart using a nuclear-tagged norepinephrine analogue, metaiodobenzylguanidine
(MIBG), allows researchers to assess myocardial innervation and the abnormal denervation that's associated with pathology.
imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
An upper abdominal extralobar sequestration must be distinguished from a suprarenal neuroblastoma, which lacks systemic arterial supply and demonstrates metaiodobenzylguanidine
(MIBG) uptake on nuclear scintigraphy.
scintigraphy and single-photon emission CT showed increased uptake in the right adrenal gland (Figure 1(b)).
in their paper "A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac 123I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors" compared the diagnostic performance of cardiovascular autonomic reflex tests with that of sympathetic innervation heart imaging with 123I metaiodobenzylguanidine
for cardiac autonomic neuropathy in type 1 DM.
Matthay, "Radiolabeled metaiodobenzylguanidine
for the treatment of neuroblastoma," Nuclear Medicine and Biology, vol.